• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT BINAXNOW; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT BINAXNOW; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM Back to Search Results
Lot Number 221443
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Viral Infection (2248)
Event Date 03/12/2023
Event Type  Injury  
Event Description
After taking paxlovid, four days later i tested positive for covid-19.No symptoms on (b)(6) 2023.Positive test was validated by using two different manufactures' test kits."pfizer".Reference report: mw5115755.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM
Manufacturer (Section D)
ABBOTT
MDR Report Key16546757
MDR Text Key311418596
Report NumberMW5115754
Device Sequence Number1
Product Code QKP
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 03/12/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date05/24/2024
Device Lot Number221443
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/14/2023
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age65 YR
Patient SexMale
Patient Weight59 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-